Literature DB >> 19418232

The impact of unmeasured baseline effect modification on estimates from an inverse probability of treatment weighted logistic model.

Joseph A C Delaney1, Robert W Platt, Samy Suissa.   

Abstract

We present the results of a Monte Carlo simulation study in which we demonstrate how strong baseline interactions between a confounding variable and a treatment can create an important difference between the marginal effect of exposure on outcome (as estimated by an inverse probability of treatment weighted logistic model) and the conditional effect (as estimated by an adjusted logistic regression model). The scenarios that we explored included one with a rare outcome and a strong and prevalent effect measure modifier where, across 1,000 simulated data sets, the estimates from an adjusted logistic regression model (mean beta = 0.475) and an inverse probability of treatment weighted logistic model (mean beta = 2.144) do not coincide with the known true effect (beta = 0.68925) when the effect measure modifier is not accounted for. When the marginal and conditional estimates do not coincide despite a rare outcome this may suggest that there is heterogeneity in the effect of treatment between individuals. Failure to specify effect measure modification in the statistical model appears to results in systematic differences between the conditional and marginal estimates. When these differences in estimates are observed, testing for or including interactions or non-linear modeling terms may be advised.

Entities:  

Mesh:

Year:  2009        PMID: 19418232     DOI: 10.1007/s10654-009-9341-z

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  23 in total

Review 1.  Commonalities in the classical, collapsibility and counterfactual concepts of confounding.

Authors:  Stephen C Newman
Journal:  J Clin Epidemiol       Date:  2004-04       Impact factor: 6.437

2.  Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures.

Authors:  Babette A Brumback; Miguel A Hernán; Sebastien J P A Haneuse; James M Robins
Journal:  Stat Med       Date:  2004-03-15       Impact factor: 2.373

3.  Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect.

Authors:  Tobias Kurth; Alexander M Walker; Robert J Glynn; K Arnold Chan; J Michael Gaziano; Klaus Berger; James M Robins
Journal:  Am J Epidemiol       Date:  2005-12-21       Impact factor: 4.897

4.  An application of model-fitting procedures for marginal structural models.

Authors:  Kathleen M Mortimer; Romain Neugebauer; Mark van der Laan; Ira B Tager
Journal:  Am J Epidemiol       Date:  2005-07-13       Impact factor: 4.897

5.  Estimating causal effects from epidemiological data.

Authors:  Miguel A Hernán; James M Robins
Journal:  J Epidemiol Community Health       Date:  2006-07       Impact factor: 3.710

6.  History-adjusted marginal structural models for estimating time-varying effect modification.

Authors:  Maya L Petersen; Steven G Deeks; Jeffrey N Martin; Mark J van der Laan
Journal:  Am J Epidemiol       Date:  2007-09-17       Impact factor: 4.897

7.  Insights into different results from different causal contrasts in the presence of effect-measure modification.

Authors:  Til Stürmer; Kenneth J Rothman; Robert J Glynn
Journal:  Pharmacoepidemiol Drug Saf       Date:  2006-10       Impact factor: 2.890

8.  Traditional versus marginal structural models to estimate the effectiveness of beta-blocker use on mortality after myocardial infarction.

Authors:  Joseph A C Delaney; Stella S Daskalopoulou; Samy Suissa
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-01       Impact factor: 2.890

9.  The importance of critically interpreting simulation studies.

Authors:  G Maldonado; S Greenland
Journal:  Epidemiology       Date:  1997-07       Impact factor: 4.822

10.  Constructing inverse probability weights for marginal structural models.

Authors:  Stephen R Cole; Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2008-08-05       Impact factor: 4.897

View more
  6 in total

1.  The positivity assumption and marginal structural models: the example of warfarin use and risk of bleeding.

Authors:  Robert William Platt; Joseph Austin Christopher Delaney; Samy Suissa
Journal:  Eur J Epidemiol       Date:  2011-12-08       Impact factor: 8.082

2.  The Shanghai Changfeng Study: a community-based prospective cohort study of chronic diseases among middle-aged and elderly: objectives and design.

Authors:  Xin Gao; Albert Hofman; Yu Hu; Huandong Lin; Chouwen Zhu; Johannes Jeekel; Xuejuan Jin; Jiyao Wang; Jian Gao; Yiqing Yin; Naiqing Zhao
Journal:  Eur J Epidemiol       Date:  2010-12-01       Impact factor: 8.082

3.  Propensity score-based sensitivity analysis method for uncontrolled confounding.

Authors:  Lingling Li; Changyu Shen; Ann C Wu; Xiaochun Li
Journal:  Am J Epidemiol       Date:  2011-06-09       Impact factor: 4.897

4.  2-Year Outcomes After Complete or Staged Procedure for Tetralogy of Fallot in Neonates.

Authors:  Jill J Savla; Jennifer A Faerber; Yuan-Shung V Huang; Theoklis Zaoutis; Elizabeth Goldmuntz; Steven M Kawut; Laura Mercer-Rosa
Journal:  J Am Coll Cardiol       Date:  2019-09-24       Impact factor: 24.094

5.  The Effects of Reverse Causality and Selective Attrition on the Relationship Between Body Mass Index and Mortality in Postmenopausal Women.

Authors:  Hailey R Banack; Jennifer W Bea; Jay S Kaufman; Andrew Stokes; Candyce H Kroenke; Marcia L Stefanick; Shirley A Beresford; Chloe E Bird; Lorena Garcia; Robert Wallace; Robert A Wild; Bette Caan; Jean Wactawski-Wende
Journal:  Am J Epidemiol       Date:  2019-10-01       Impact factor: 4.897

6.  The Generation R Study: design and cohort update 2010.

Authors:  Vincent W V Jaddoe; Cock M van Duijn; Albert J van der Heijden; Johan P Mackenbach; Henriëtte A Moll; Eric A P Steegers; Henning Tiemeier; Andre G Uitterlinden; Frank C Verhulst; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2010-10-22       Impact factor: 8.082

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.